KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 88 days ( 10.86 % )
Last Price $1.56 4.00 %
High/ Low $1.49 - $1.60 6.71%
Chg 7 Days 3.31 % $1.51 $1.56
Chg 30 Days -7.14 % $1.68 $1.56
Chg 12 mos 271.43 % $0.420 $1.56
Trend - 3 mos -7.88 % Width: 9.39 %
Trend - 12 mos -32.12 % Width: 365.58 %
Pred. range - 3 mos $1.37 - $1.50 -12.00 % - -3.74 %
Pred. range - 12 mos N/A - $3.05 -100.00 % - 95.24 %
Short MA avg 3 mos Buy Jan 26, 2023 - 2 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Jan 26, 2023 - 2 days
Long MA avg 12 mos Sell May 10, 2022 - 181 days
Short/Long MA avg 12 mos Sell May 18, 2022 - 175 days
Pivot Short Buy Jan 26, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Celsion Corporation

Celsion Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company als... CLSN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT